Ethionamide-induced gynecomastia: A rare case report
Abstract Gynecomastia is a rare side effect of antitubercular chemotherapy. A 22-year-old male patient was diagnosed as a multidrug-resistant tuberculosis case and was put on standard second-line antituberculosis drugs. Two months later, the patient developed painful enlarged left breast with size 2...
Main Authors: | Sourindra N. Banerjee, Rupam K. Ta, Md. Salim Mallick, Manish K. Munda |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2017-01-01
|
Series: | The Egyptian Journal of Bronchology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.4103/1687-8426.198998 |
Similar Items
-
EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide
by: Ang, Michelle L. T., et al.
Published: (2017) -
How a PCR Sequencing Strategy Can Bring New Data to Improve the Diagnosis of Ethionamide Resistance
by: Thomas Maitre, et al.
Published: (2022-07-01) -
Molecular Determinants of Ethionamide Resistance in Clinical Isolates of <i>Mycobacterium tuberculosis</i>
by: Anastasia Ushtanit, et al.
Published: (2022-01-01) -
Study of ethA gene sequence in Ethionamide resistant clinical isolates of Mycobacterium tuberculosis
by: Somaye Moazemi, et al.
Published: (2015-01-01) -
Phenotypic low-level isoniazid resistance as a marker to predict ethionamide resistance in Mycobacterium tuberculosis
by: Salima Qamar, et al.
Published: (2017-01-01)